w o m e n ’ s HEALTH •Your Hormone Options UPDATES •Questions to Ask
National Women’s Health Resource Center, Inc.
produced during your menopausalyears; and estriol, or E3, the weakest
Hormone Therapy Options: form of estrogen, primarily avail-
able during pregnancy when it isproduced by the placenta. Each
form works differently in differentparts of your body. ith all the bad news about hormone replacement therapy
Fact 2.“Natural” is a mar- over the past few years, is it keting term, not a any wonder that more women than medical term. Just because a medica- ever are now searching for alternatives to treat their menopausal symptoms?
symptoms they’d thought long gone.
ral” doesn’t mean it’s any safer than
type of therapy best meets her individual
to follow any of these requirements.
Fact 1.Your body produces three different kinds
Fact 3. Women today can of estrogen. These are: estradiol, or choose from many options to treat their menopausal symptoms. It is important to under-
“bi-estrogen” or “tri-estrogen,” since
saliva testing is not reliable; nor is it
Fact 5.If hormonetherapy is used to determine dosage or to mon- indicated, the FDA recommends that it should be pre- scribed at the lowest effective dose Safety and Regulation of for the shortest time needed. Using Bioidentical Hormones
all women who choose to use hor-mone therapy. Your health care pro-
from pills to creams to patches to a gel.
Fact 4. As with any med- varying doses and hormone therapy cy studies (i.e., studies showing how ication, all forms of hormone therapy have the poten- tial for side effects. Whether it was Defining Bioidentical
When something is “bioidenti- are no guidelines for their use.4
have certain side effects and risks.
National Women’s Health Resource Center
March 2005 Your Hormone Options
Women have numerous FDA- are generally used only to treat toms, including hot flashes and
months, at which point it is replaced.
(thighs and calves) on a daily basis. Therapy & Other Options,” available
National Women’s Health Resource Center
Start with Your Symptoms Resources
The new approach to hormone American College of Obstetricians and Gynecologists If you are considering using hormone therapy to treat menopausal symptoms, ask your health care professional
education on women’s health conditions. these questions: American Menopause Foundation 1. Why should I take hormone therapy? 2. Which hormone therapy delivery method is right for me? 3. Could you please review the term “bioidentical” with me? 4. What is the lowest dose of National Institutes of Health Menopausal Hormone Therapy hormone therapy that I can Information take to relieve my symptoms? 5. How long should I take hormone therapy? 6. What side effects are possible with this medication?
increasing it until you’re comfortable,
National Women’s Health 7. What are the risks associated Resource Center, Inc. with this medication?
157 Broad Street, Suite 315Red Bank, NJ 07701
References Bioidentical Hormones
National Women’s Health Resource Center
North American Menopause
2 Subcommittee on Human Rights and Wellness.
House Committee on Government Reform. “Balancing Act: The Health Advantages
information to women interested in making
3 EstroGel [package insert]. Marietta, GA.
informed decisions about their health. This
information does not suggest individual diagnosis
4 “Hormone Therapy: Fact or Fiction.
or treatment. This publication is not a substitute
for medical attention. The publisher cannot
accept responsibility for application of the
5 North American Menopause Society Position
National Association of Nurse
conditions. The National Women’s Health
associated vasomotor symptoms.” Menopause:Practitioners in Women’s Health
Resource Center does not endorse or promote any
Menopause Society. 2004; 11(1): 11 – 33.
6 Femring [package insert]. Rockaway, NJ:
2005 NWHRC. All rights reserved. Reproduction
of material published in the Women’s Health
Update is encouraged with written permission
7 Estring [package insert]. Kalamazoo, MI:
from NWHRC. Write to address above or call toll-
8 Vagifem [package insert]. Princeton, NJ:
9 Delestrogen [package insert]. Bristol, TN:
support of Solvay Pharmaceuticals, Inc.
SOLU-MEDROL Sterile Powder NAME OF MEDICINAL PRODUCT QUALITATIVE AND QUANTITATIVE COMPOSITION Active Ingredient: Methylprednisolone sodium succinateMethylprednisolone sodium succinate is available for intravenous or intramuscular administration as: Act-O-Vial System (Single-Dose Vial) 40mg/mL containing methylprednisolone sodium succinate equivalent to 40 mg methylprednisolone. 1
Research letters Congenital anomalies after prenatal ecstasy exposure P R McElhatton, D N Bateman, C Evans, K R Pughe, S H L Prospective follow-up of 136 babies exposed to ecstasy in utero74 pregnant women reported taking ecstasy only and 62indicated that the drug may be associated with a significantlytook ecstasy with other drugs of abuse (ecstasy andincreased risk of congenital defect